Published October 2013 | Version v1
Journal article

Comparison [3H]-flumazenil binding parameters in rat cortical membrane using different separation methods, filtration and centrifugation

  • 1. Department of Radiopharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran (Iran, Islamic Republic of)
  • 2. Department of Pharmacology and Toxicology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran (Iran, Islamic Republic of)
  • 3. Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran (Iran, Islamic Republic of)
  • 4. Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran (Iran, Islamic Republic of)

Description

Radioligand receptor binding assays are a common method to evaluate the affinity of newly synthesized benzodiazepine ligands for the receptor. [3H]-flumazenil is an antagonist of benzodiazepine receptors and is generally used as a radioligand. In this study, the binding parameters of [3H]-flumazenil to rat cortical membranes were evaluated using two separation methods: filtration with GF/C filters and centrifugation. Additionally, the effects of vacuum pressure, exposure time to the cocktail, and geometry on the filtration method were studied. The binding parameters of [3H]-flumazenil (Kd and Bmax) were determined through saturation studies using two methods. The results from this study showed that the filtration method is time consuming and requires more steps to be completed. Because filtration causes partial elution of bound [3H]-flumazenil into the liquid scintillation cocktail, the results are not reproducible, which result in inaccurate estimation of the binding parameters. The centrifugation method in contrast to filtration is straightforward and produces reproducible as well as reliable results, all of the steps are performed in a single polypropylene tube, which eliminates the loss of tissue and avoids other systematic errors associated with transfer and handling

Availability note (English)

Available from http://dx.doi.org/10.1016/j.nucmedbio.2013.06.010

Additional details

Identifiers

DOI
10.1016/j.nucmedbio.2013.06.010;
PII
S0969-8051(13)00125-X;

Publishing Information

Journal Title
Nuclear Medicine and Biology
Journal Volume
40
Journal Issue
7
Journal Page Range
p. 896-900
ISSN
0969-8051
CODEN
NMBIEO

Optional Information

Copyright
Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.